Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) EPS (Weighted Average and Diluted) (2018 - 2025)

Select Medical Holdings (SEM) has disclosed EPS (Weighted Average and Diluted) for 8 consecutive years, with $0.16 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 70.91% to $0.16 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.16, a 30.12% decrease, with the full-year FY2025 number at $1.16, down 30.12% from a year prior.
  • EPS (Weighted Average and Diluted) was $0.16 for Q4 2025 at Select Medical Holdings, down from $0.24 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.75 in Q1 2024 to a low of -$1.13 in Q4 2022.
  • A 5-year average of $0.23 and a median of $0.23 in 2025 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): crashed 405.41% in 2022, then skyrocketed 1050.0% in 2024.
  • Select Medical Holdings' EPS (Weighted Average and Diluted) stood at $0.37 in 2021, then plummeted by 405.41% to -$1.13 in 2022, then soared by 110.62% to $0.12 in 2023, then skyrocketed by 358.33% to $0.55 in 2024, then crashed by 70.91% to $0.16 in 2025.
  • Per Business Quant, the three most recent readings for SEM's EPS (Weighted Average and Diluted) are $0.16 (Q4 2025), $0.24 (Q3 2025), and $0.32 (Q2 2025).